Zeng Yukai, Wang Guanghui, Zheng Haotian, et al. Development and internal validation of a prognostic model of metachronous dual primary lung cancer based on SEER database. [J]. Journal of Shanxi Agricultural Sciences 47(10):1199-1205(2022)
DOI:
Zeng Yukai, Wang Guanghui, Zheng Haotian, et al. Development and internal validation of a prognostic model of metachronous dual primary lung cancer based on SEER database. [J]. Journal of Shanxi Agricultural Sciences 47(10):1199-1205(2022) DOI: 10.13406/j.cnki.cyxb.003101.
Development and internal validation of a prognostic model of metachronous dual primary lung cancer based on SEER database
通过美国癌症监测、流行病学和结果(Surveillance,Epidemiology and End Results,SEER)数据库获得mDPLC患者的临床数据。将数据分为训练集和验证集进行建模和验证。采用单因素和多因素Cox回归分析确定训练集患者的独立预后因素,并纳入列线图对患者生存时间进行预测。通过C-指数、校准图、受试者工作特征(receiver operating characteristic,ROC)曲线、决策曲线分析(decision curve analyses,DCA)和综合鉴别改进(integrated discrimination improvement,IDI)评分对预后模型的准确性和可靠性进行评价。
To explore independent prognostic factors of metachronous dual primary lung cancer(mDPLC) by using retrospective analysis,and establish a prognostic nomogram model.
Methods:
2
Clinical information of mDPLC patients was collected from Surveillance,Epidemiology,and End Results(SEER) database. The dataset was divided into training and validation sets for modeling and validation. Univariate and multivariable Cox regression analyses were used to explore independent prognostic factors of training set,and the survival time of patients was predicted by nomogram. The accuracy and reliability of the prognostic model were evaluated by C-indexes,calibration plots,receiver operating characteristic(ROC) curves,decision curve analyses(DCA) and integrated discrimination improvement(IDI) scores.
Results:
2
A total of 610 mDPLC patients were included in the training set,and 260 mDPLC patients were included in the validation set. Cox regression analysis showed that age(59-76:HR=1.453,95%CI=1.007-2.096,
=0.007) and chemotherapy(yes + no:HR=0.603,95%CI=0.433-0.842,
P
=0.003) were independent prognostic factors. The C-index of training set and verification set were 0.711(95%CI=0.696-0.726,
P
<
0.05) and 0.677(95%CI=0.655-0.699,
P
<
0.05),respectively. The AUC values of 3-year survival rate and 5-year survival rate of ROC curve in training set were 0.756(95%CI=0.713-0.800,
P
<
0.05) and 0.785(95%CI=0.732-0.838,
P
<
0.05),respectively,and the AUC values of the 3-year survival rate and 5-year survival rate of the ROC curve in validation set were 0.695(95%CI=0.621-0.769,
P
<
0.05) and 0.711(95%CI=0.618-0.804,
P
<
0.05). IDI values of 3 and 5 years were 9.0%(
P
<
0.001) and 11.9%(
P
<
0.001) in the training set,and 6.6%(
P
<
0.001) and 7.8%(
P
<
0.001) in the validation set,respectively. The internal validation showed that the predictive effect of the novel prognostic model was accurate and reliable and was better than that of the model based on TNM system.
Conclusion:
2
This study has established a prognostic prediction model of mDPLC,and the internal validation has shown good efficiency,which could provide accurate and personalized survival prediction for mDPLC patients.
关键词
异时双原发肺癌预测模型列线图Cox回归分析美国癌症监测、流行病学和结果数据库
Keywords
metachronous dual primary lung cancerprediction modelnomogramCox regression analysisSurveillance Epidemiology and End Results database
Construction and validation of a predictive model for the prognosis of papillary renal cell carcinoma: a retrospective study based on the Surveillance,Epidemiology,and End Results database
Construction and validation of a nomogram prediction model for new-onset atrial fibrillation during hospitalization in patients with acute ST-elevation myocardial infarction
Correlation analysis and prediction model construction of CT signs and infiltration degree of pure ground-glass nodule lung adenocarcinoma
Identification of high risk patients with preoperative low albumin for advanced gastric antrum cancer based on nomogram model
Establishment and validation prediction models of benign and malignant predictors for solitary pulmonary nodules
Related Author
Jiang Qing
Wang Jiawu
Xiao Jun
Ao Qinrong
Pang Xiao
Cheng Xin
Xu Gang
Zhang Ying
Related Institution
Department of Urology,the Second Affiliated Hospital of Chongqing Medical University
Department of Cardiovascular Medicine,Chongqing Emergency Medical Center/The Fourth People’s Hospital of Chongqing
Department of Cardiothoracic Surgery,The First Affiliated Hospital of Chongqing Medical University
Department of Gastrointestinal Surgical Oncology,Fujian Cancer Hospital/ Fujian Medical University Cancer Hospital
Department of Respiratory and Critical Care Medicine, Chongqing Medical University